PVAG-14 Pilot for Intermediate Stages Hodgkin Lymphoma

NCT00512980 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

OTHER

Sponsor class

Stopped lower recruitment rates as expected

Conditions

Hodgkin Lymphoma

Interventions

DRUG: prednisone
DRUG: vinblastine
DRUG: doxorubicin
DRUG: gemcitabine

Sponsor

University of Cologne